发明授权
US06800434B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus
有权
肽作为丙型肝炎病毒的NS3-丝氨酸蛋白酶抑制剂
- 专利标题： Peptides as NS3-serine protease inhibitors of hepatitis C virus
- 专利标题（中）： 肽作为丙型肝炎病毒的NS3-丝氨酸蛋白酶抑制剂
-
申请号： US09909062申请日： 2001-07-19
-
公开(公告)号： US06800434B2公开(公告)日： 2004-10-05
- 发明人: Anil K. Saksena , Viyyoor Moopil Girijavallabhan , Raymond G. Lovey , Edwin Jao , Frank Bennett , Jinping L. McCormick , Haiyan Wang , Russell E. Pike , Stephane L. Bogen , Yi-Tsung Liu , Ashok Arasappan , Tejal Parekh , Patrick A. Pinto , F. George Njoroge , Ashit K. Ganguly , Terence K. Brunck , Scott Jeffrey Kemp , Odile Esther Levy , Marguerita Lim-Wilby
- 申请人： Anil K. Saksena , Viyyoor Moopil Girijavallabhan , Raymond G. Lovey , Edwin Jao , Frank Bennett , Jinping L. McCormick , Haiyan Wang , Russell E. Pike , Stephane L. Bogen , Yi-Tsung Liu , Ashok Arasappan , Tejal Parekh , Patrick A. Pinto , F. George Njoroge , Ashit K. Ganguly , Terence K. Brunck , Scott Jeffrey Kemp , Odile Esther Levy , Marguerita Lim-Wilby
- 主分类号： A61K3800
- IPC分类号： A61K3800
摘要：
The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such peptides as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
